Electsita-DM Tablet ER
Marketer
Elect-Us Life Sciences
Salt Composition
Dapagliflozin (10mg) + Metformin (500mg) + Sitagliptin (100mg)
Overview Electsita-DM Tablet ER
GlycoBalance XR is a dual-action formulation designed to manage blood glucose. In conjunction with diet and exercise, it enhances glycemic control in adult patients with type 2 diabetes. It facilitates improved insulin responsiveness, resulting in reduced blood sugar. GlycoBalance XR may be administered with or without food, consistently at the same time each day. Dosage should be determined by your physician; discontinuation without medical consultation is strongly discouraged, as this can elevate blood sugar levels and raise the risk of severe complications, such as renal impairment and vision loss. This medication forms part of a comprehensive treatment plan encompassing a balanced diet, regular physical activity, and appropriate weight management as directed by your doctor. Commonly reported adverse effects include urinary tract infections, nasal congestion, pharyngitis, and upper respiratory infections. Adequate hydration is crucial to minimize dehydration. Genital yeast infections may occur in some individuals; good hygiene practices can help mitigate this risk. Prior to commencing GlycoBalance XR, consult your physician if you have hepatic or renal dysfunction, a urinary tract infection, or are using diuretics. Pregnant or lactating women should seek medical advice before use. Excessive alcohol consumption should be avoided, as this may potentiate side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Electsita-DM Tablet ER
No text provided. Please provide the text you wish to be rephrased.
Uses of Electsita-DM Tablet ER
Managing type 2 diabetes
Major Benefits of Electsita-DM Tablet ER:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid crushing, chewing, or fracturing it. Electsita-DM Extended-Release Tablets may be consumed with or without food, although consistent timing is recommended.
Common Side effects of Electsita-DM Tablet ER:
- Diarrhea
- Nausea
- Vomiting
- Flatulence
- Polyuria
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
- Headache
- Hypoglycemia (low blood glucose level)
- Cough
How to use Electsita-DM Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Electsita-DM Tablet ER. The tablet should be swallowed whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistency is key—take it at the same time each day.
How Electsita-DM Tablet ER works:
Electsita-DM Extended-Release tablets contain a triple-action formula to manage diabetes. Dapagliflozin promotes increased glucose elimination via the urine, thereby lowering blood glucose. Metformin works in several ways: it reduces glucose absorption from ingested food, lessens the liver's glucose production, and enhances the body's insulin sensitivity. This improves the body's natural blood sugar regulation. Sitagliptin boosts incretin levels, prompting the pancreas to release more insulin and simultaneously inhibiting excess glucose production by the liver.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The interaction between Electsita-DM Tablet ER and alcohol is unknown. A physician's advice is recommended.
PregnancyCONSULT YOUR DOCTOR
Data on Electsita-DM Tablet ER use in pregnancy is currently unavailable. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Data on Electsita-DM Tablet ER use while breastfeeding is absent. Seek medical advice from your physician.
DrivingUNSAFE
Taking Electsita-DM Extended-Release Tablets might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Electsita-DM Tablet ER use in patients suffering from renal impairment. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Electsita-DM Tablet ER use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Electsita-DM Tablet ER :
Should you forget to take your Electsita-DM Tablet ER, administer it immediately upon recollection. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Electsita-DM Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |


